dactylitis, elevated levels of inflammation mark-ers such as ESR and CRP attributable to PsA), long-term damage that interferes with function (e.g., joint deformities), highly active disease that causes a major impairment in quality of life (i.e., active psoriatic inflammatory disease at many sites [including dactylitis, enthesitis] or function-limiting inflammatory disease at few sites), and rapidly progressive disease (Figure 2 2 The panels chose the critical outcomes for all comparisons at